EyePromise announced the launch of Heyedrate Clinical, a next-generation artificial tear designed to deliver fast-acting temporary relief for individuals experiencing dry eye symptoms. With povidone and the highest molecular weight hyaluronic acid (Hylan A) available in the United States, Heyedrate Clinical is preservative-free, triple filtered, and adapts with every blink to mimic the comfort and feel of natural tears, according to the company. Heyedrate Clinical joins a portfolio of products that includes De3, a supplement for occasional dry eye in the United States; and Avenova Lid & Lash Cleansing Spray, an HOCI lid and lash cleanser. Heyedrate Clinical is now available for purchase at www.EyePromise.com.
News
EyePromise Introduces Heyedrate Clinical
The artificial tear is designed to deliver fast-acting temporary relief for individuals experiencing dry eye symptoms
Optometric Management
May 19, 2026


